Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Sell
33
DOCS Quote, Financials, Valuation and Earnings
Last price:
$45.69
Seasonality move
:
1.13%
Day range:
$43.42 - $46.16
52-week range:
$43.21 - $85.21
Dividend yield:
0%
P/E ratio:
36.44x
P/S ratio:
14.84x
P/B ratio:
7.85x
Volume:
3.7M
Avg. volume:
2.7M
1-year change:
-17.26%
Market cap:
$8.6B
Revenue:
$570.4M
EPS (TTM):
$1.25
Analysts' Opinion
-
Consensus RatingDoximity, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 8 Buy ratings, 6 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $67.90, Doximity, Inc. has an estimated upside of 48.61% from its current price of $45.69.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $45.00 representing 100% downside risk from its current price of $45.69.
Fair Value
-
According to the consensus of 15 analysts, Doximity, Inc. has 48.61% upside to fair value with a price target of $67.90 per share.
DOCS vs. S&P 500
-
Over the past 5 trading days, Doximity, Inc. has overperformed the S&P 500 by 3.72% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Doximity, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Doximity, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Doximity, Inc. reported revenues of $168.5M.
Earnings Growth
-
Doximity, Inc. has grown year-over-year earnings for 10 quarters straight. In the most recent quarter Doximity, Inc. reported earnings per share of $0.31.
Enterprise value:
7.7B
EV / Invested capital:
--
Price / LTM sales:
14.84x
EV / EBIT:
30.76x
EV / Revenue:
12.45x
PEG ratio (5yr expected):
0.82x
EV / Free cash flow:
24.78x
Price / Operating cash flow:
29.54x
Enterprise value / EBITDA:
29.39x
Gross Profit (TTM):
$560.5M
Return On Assets:
21%
Net Income Margin (TTM):
40.73%
Return On Equity:
24.35%
Return On Invested Capital:
24.06%
Operating Margin:
40.28%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $448.3M | $516.8M | $621.3M | $136.8M | $168.5M | |
| Gross Profit | $395.2M | $464.9M | $560.5M | $123.2M | $152.1M | |
| Operating Income | $143.7M | $203M | $251.4M | $55.7M | $67.9M | |
| EBITDA | $156.4M | $213.2M | $263.2M | $58.3M | $71.4M | |
| Diluted EPS | $0.58 | $0.87 | $1.25 | $0.22 | $0.31 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $826.5M | $844.9M | $859.9M | $954.3M | $1.1B | |
| Total Assets | $869.3M | $1B | $1B | $1.1B | $1.3B | |
| Current Liabilities | $95.6M | $118.1M | $123.2M | $132.3M | $140.3M | |
| Total Liabilities | $96.7M | $149.4M | $154.1M | $157.3M | $161.6M | |
| Total Equity | $772.6M | $879M | $871.5M | $961.2M | $1.1B | |
| Total Debt | $118K | $14.6M | $13.1M | $11.3M | $9.1M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $165.4M | $223.6M | $319.7M | $68.3M | $93.9M | |
| Cash From Investing | $67.3M | $18.1M | -$112.4M | $24.2M | -$31.7M | |
| Cash From Financing | -$198M | -$165.8M | -$222.3M | -$19.7M | -$30.2M | |
| Free Cash Flow | $160.3M | $217.4M | $312.1M | $66.8M | $91.6M | |
DOCS
Sector
Market Cap
$8.6B
$28.1M
Price % of 52-Week High
53.62%
50.9%
Dividend Yield
0%
0%
Shareholder Yield
1.26%
-1.55%
1-Year Price Total Return
-17.26%
-19.36%
Beta (5-Year)
--
0.498
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$44.35
200-day SMA
Sell
Level
$59.15
Bollinger Bands (100)
Sell
Level
49.72 - 71.46
Chaikin Money Flow
Buy
Level
14.9M
20-day SMA
Buy
Level
$44.76
Relative Strength Index (RSI14)
Sell
Level
46.01
ADX Line
Sell
Level
40.17
Williams %R
Neutral
Level
-28.0012
50-day SMA
Sell
Level
$51.87
MACD (12, 26)
Sell
Level
-1.98
25-day Aroon Oscillator
Sell
Level
-92
On Balance Volume
Neutral
Level
14.3M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (36.9068)
Buy
CA Score
(Annual)
Level (2.1743)
Buy
Beneish M-Score
(Annual)
Level (-2.4392)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-5.8662)
Buy
Piotroski F Score
(Annual)
Level (9)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Doximity, Inc. engages in the development and operation of an online platform for medical professionals. Its cloud-based software has the ability to enable users to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. The company was founded by Shari Buck, Konstantin Guericke, Nate Gross, and Jeffrey A. Tangney on April 16, 2010 and is headquartered in San Francisco, CA.
Stock Forecast FAQ
In the current month, DOCS has received 8 Buy ratings 6 Hold ratings, and 1 Sell ratings. The DOCS average analyst price target in the past 3 months is $67.90.
-
Where Will Doximity, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Doximity, Inc. share price will rise to $67.90 per share over the next 12 months.
-
What Do Analysts Say About Doximity, Inc.?
Analysts are divided on their view about Doximity, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Doximity, Inc. is a Sell and believe this share price will drop from its current level to $45.00.
-
What Is Doximity, Inc.'s Price Target?
The price target for Doximity, Inc. over the next 1-year time period is forecast to be $67.90 according to 15 Wall Street analysts, 8 of them rate the stock a Buy, 1 rates the stock a Sell, and 6 analysts rate the stock a Hold.
-
Is DOCS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Doximity, Inc. is a Buy. 8 of 15 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of DOCS?
You can purchase shares of Doximity, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Doximity, Inc. shares.
-
What Is The Doximity, Inc. Share Price Today?
Doximity, Inc. was last trading at $45.69 per share. This represents the most recent stock quote for Doximity, Inc.. Yesterday, Doximity, Inc. closed at $45.69 per share.
-
How To Buy Doximity, Inc. Stock Online?
In order to purchase Doximity, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get DOCS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
DOCS
Sector
P/E ratio
36.44x
24.09x
PEG ratio
0.82x
-0.01x
P/B ratio
7.85x
1.83x
Price / LTM sales
14.84x
1.59x
Growth Metrics
DOCS
Sector
Revenue growth
23.16%
4.68%
Earnings growth
40.31%
10.88%
Revenue (5-year growth)
37.42%
6.45%
Earnings forecast
$0.45
-$0.18
Profitability
DOCS
Sector
Profitability FY 2024
$514.5M
$3.6M
Return on invested capital
24.06%
-31.87%
Return on assets
21%
-28.18%
Return on equity
24.35%
-37.89%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Feb
5
Estimated Next Earnings Date
Feb
5
Balance Sheet
DOCS
Sector
Total cash
$878.4M
$26.2M
Short term investments
$706.1M
$25.7M
Total assets
$1.3B
$76.7M
Long term debt
$9.1M
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 36x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
64
RGC alert for Jan 6
Regencell Bioscience Holdings Ltd. [RGC] is up 22.74% over the past day.
Buy
73
INOD alert for Jan 6
Innodata, Inc. [INOD] is up 4.84% over the past day.
Buy
65
AVAV alert for Jan 6
AeroVironment, Inc. [AVAV] is up 6.62% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
